The story of Viagra presents a complex picture for investors. While the initial release generated substantial gains, the end of its intellectual property protection opened the door to generic alternatives, dramatically https://sahilxazb551201.blogoscience.com/48547427/the-copyright-and-big-pharma-a-volatile-opportunity